Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 7Terminated 4Recruiting 3Unknown 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 74Head & Neck 20Tumor-Agnostic 4Thoracic 4Breast 3Gynecologic 2Dermatologic 1CNS 1

Conditions

Uterine Cervical Neoplasms 2

Interventions

Paclitaxel 77Carboplatin 71Cisplatin 70Radiotherapy 27Bevacizumab 27Brachytherapy 23Hyperthermic Intraperitoneal Chemotherapy 20Drug Therapy 20olaparib 18Gemcitabine 17niraparib 16apatinib 16pembrolizumab 15Surgical Procedures, Operative 14liposomal doxorubicin 12Cyclophosphamide 12Surveys and Questionnaires 11camrelizumab 10Neoadjuvant Therapy 10fludarabine 9anlotinib 9Taxes 9Etoposide 9Blood Specimen Collection 9Topotecan 8Docetaxel 8Sentinel Lymph Node Biopsy 7Platinum 7Cytoreduction Surgical Procedures 7Albumin-Bound Paclitaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Cetuximab × Gynecologic × Clear all
NCT00997009 2023-11-14

MITO CERV 2

National Cancer Institute, Naples

Phase 2 Unknown
108 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00292955 2011-05-30

Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma

University of Virginia

Phase 2 Unknown
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡